Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01008280
What this trial is testing

Baclofen to Reduce Alcohol Use in Veterans With HCV

Who this might be right for
Hepatitis CAlcohol Use Disorders
VA Office of Research and Development 180
Post-approval studies (Phase 4)Study completedNCT02641379
What this trial is testing

Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 737
Post-approval studies (Phase 4)UnknownNCT04244383
What this trial is testing

Expression of Inflammasomes in HCV Patients

Who this might be right for
Hepatitis C
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT03118674
What this trial is testing

Harvoni Treatment Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea TardaHepatitis C
Wake Forest University Health Sciences 23
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Testing effectiveness (Phase 2)Study completedNCT00211848
What this trial is testing

Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers

Who this might be right for
Hepatitis C
Icahn School of Medicine at Mount Sinai 207
Early research (Phase 1)Study completedNCT01275599
What this trial is testing

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Who this might be right for
Hepatitis COpioid-Related Disorders
Vertex Pharmaceuticals Incorporated 16
Early research (Phase 1)Study completedNCT00793793
What this trial is testing

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Early research (Phase 1)Study completedNCT00489385
What this trial is testing

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Who this might be right for
HIV InfectionsHCV
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableEnded earlyNCT03981211
What this trial is testing

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

Who this might be right for
Hepatitis CLiver InflammationLiver Cirrhoses
Kirby Institute 21
Post-approval studies (Phase 4)Ended earlyNCT00456248
What this trial is testing

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

Who this might be right for
Hepatitis C
Kadmon Corporation, LLC 5
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Not applicableEnded earlyNCT01639547
What this trial is testing

Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Chang Gung Memorial Hospital 410
Not applicableStudy completedNCT02578693
What this trial is testing

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 1,210
Not applicableUnknownNCT01953458
What this trial is testing

Therapeutic Option for Hepatitis B and C: a French Cohort

Who this might be right for
Viral Hepatitis BViral Hepatitis C
ANRS, Emerging Infectious Diseases 20,902
Post-approval studies (Phase 4)Study completedNCT01327547
What this trial is testing

Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Who this might be right for
HIV Coinfection
ViiV Healthcare 138
Not applicableStudy completedNCT03111966
What this trial is testing

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Who this might be right for
Hepatitis C
Hepa C 130
Post-approval studies (Phase 4)UnknownNCT04625322
What this trial is testing

HCV Treatment Initiation During Acute Psychiatric Admission

Who this might be right for
Hepatitis C
University Health Network, Toronto 54
Not applicableStudy completedNCT00959166
What this trial is testing

To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection

Who this might be right for
Acute Hepatitis CHIVHIV Infections
Imperial College London 81
Not applicableActive Not RecruitingNCT05992077
What this trial is testing

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

Who this might be right for
HCV Infection
ANRS, Emerging Infectious Diseases 21,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation